Protein Expression Systems Market

Protein Expression Systems Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Protein expression is an integral tool in biological research and it is gaining significant traction as a
pharmaceutical production mechanism for biological therapeutics. The biotechnology industry uses
both cell types prokaryotic (bacteria) and eukaryotic (animal, fungi, and plant) to synthesize
recombinant proteins. The choice of the host cell depends on the protein expressed. The demand for
recombinant proteins has increased as more applications in several fields are commercially available.
Recombinant proteins have been utilized as tools for cellular and molecular biology.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/2383
The demand for protein therapeutics has increased considerably, owing to increase in prevalence of
chronic diseases and development of plasma-derived therapies. In recent years, proteins expression
systems have gained significant traction for therapeutic applications and the number of proteins
launched or approved into clinical trials has continually increased. According to the National Center
for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA)
approved more than 140 recombinant therapeutic proteins for human use and several hundred are
currently in development.
Increasing demand for protein therapeutics is expected to drive the protein
expression systems market revenue
Rising incidence of various diseases such as cancer, cardiovascular conditions, and genetic
disorders is the major factor driving growth of protein expression system market. For instance,
protein-based drugs such as insulin, can treat a wide variety of conditions with remarkable
effectiveness. Moreover, high efficiency of protein therapeutics and minimum risk of side effects
associated with protein therapeutics is attracting manufacturers to invest in the protein
expression systems research and development. Recombinant proteins such as enzymes and
biologics are useful in the biopharmaceutical, chemical, and food industries.
Report includes chapters which deeply display the following deliverable about industry :
• Protein Expression Systems Market Research Objective and Assumption
• Protein Expression Systems Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Protein Expression Systems Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Protein Expression Systems Market, By Regions
• Protein Expression Systems Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Protein Expression Systems Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Protein Expression Systems Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Protein Expression Systems Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Protein Expression Systems Market - Competitive Landscape
Key players operating in the global protein expression systems market include Agilent
Technologies, Inc., Becton, Dickinson & Company, Lonza Group Ltd., GenScript Biotech
Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, QIAGEN N.V., Thermo Fisher
Scientific Inc., Takara Bio Inc., Synthetic Genomics Inc., Lucigen Corporation, Promega
Corporation, ARTES Biotechnology GmbH, ProteoGenix, Addgene Inc., Geneva Biotech,
Profacgen, and Peak Proteins Ltd.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2383
Detailed Segmentation:
• Global Protein Expression Systems Market,
• Mammalian Expression Systems
• Insect Expression Systems
• Bacterial Expression Systems
• Plant Expression Systems
• Yeast Expression Systems
• Cell Free Expression Systems
• Global Protein Expression Systems Market,
• Competent Cells
• Instruments
• Reagents
• Others
• Global Protein Expression Systems Market,
• Protein Therapeutics
• Research Studies
• Global Protein Expression Systems Market,
• North America
By Expression System:
By Product Type:
By Application:
By Region:
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report